
Maple Cross Remedies Private Limited
Pharmaceutical company trading various drugs, vitamins, and healthcare products globally since 2001.
Pharmaceutical company trading various drugs, vitamins, and healthcare products globally since 2001.
Maple Cross Remedies Private Limited (MCRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 June 2001 and has a history of 23 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.57 Cr. The company has closed loans amounting to ₹3.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anuj Shahani, Mahesh Bakhru, Jaikishan Shahani, and Three other members serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U85199MH2001PTC132312
132312
Private Limited Indian Non-Government Company
12 Jun 2001
30 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anuj Shahani ![]() | Director | 16-Aug-2005 | Current |
Mahesh Bakhru ![]() | Director | 12-Jun-2001 | Current |
Jaikishan Shahani ![]() | Director | 12-Jun-2001 | Current |
Deepika Shahani ![]() | Director | 26-May-2015 | Current |
Roma Bakhru ![]() | Director | 26-May-2015 | Current |
Usha Shahani ![]() | Director | 26-May-2015 | Current |
Maple Cross Remedies Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.05% decrease. The company also saw a slight improvement in profitability, with a 4.54% increase in profit. The company's net worth Soared by an impressive increase of 17.62%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Maple Cross Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Anuj Shahani and Mahesh Bakhru are mutual person
Anuj Shahani, Mahesh Bakhru and 4 more are mutual person
₹15.68 M
₹32.58 M
Date | Lender | Amount | Status |
---|---|---|---|
02 Mar 2024 | Hdfc Bank Limited | ₹2.58 M | Open |
03 Mar 2022 | Hdfc Bank Limited | ₹1.50 M | Open |
30 Jun 2021 | Others | ₹1.01 Cr | Open |
12 Jan 2005 | Corporation Bank | ₹1.50 M | Open |
12 May 2021 | Others | ₹2.70 Cr | Satisfied |
Unlock and access historical data on people associated with Maple Cross Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maple Cross Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Cross Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 2.58 M with Charge ID 100892934 was registered on 02 Mar 2024.
Maple Cross Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Maple Cross Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
A charge registered on 24 May 2017 via Charge ID 100127537 with Hdfc Bank Limited was fully satisfied on 25 Jul 2022.
A charge with Hdfc Bank Limited amounted to Rs. 1.50 M with Charge ID 100552411 was registered on 03 Mar 2022.
A charge registered on 12 May 2021 via Charge ID 100445465 with Others was fully satisfied on 24 Sep 2021.
Maple Cross Remedies Private Limited was incorporated on 12 Jun 2001.
The authorized share capital of Maple Cross Remedies Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 6 directors are associated with Maple Cross Remedies Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Maple Cross Remedies Private Limited is F-714 Autumn Grove Chs Ltd. Akurli Road Near Lokhandwala Foundation School, Kand Ivali (E) India, Mumbai, Maharashtra, 400101.
The corporate identification number (CIN) of Maple Cross Remedies Private Limited is U85199MH2001PTC132312 and the company number is 132312 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Maple Cross Remedies Private Limited has fallen by -0.05%.
The financial reports for the fiscal year 2023 indicates that The net worth of Maple Cross Remedies Private Limited has experienced an upsurge of 17.62%.
As per the financial statements for fiscal Year 2023, The total open charges for Maple Cross Remedies Private Limited amount to ₹ 1.57 Cr.
The most recent Balance Sheet for Maple Cross Remedies Private Limited was filed with the ROC on 31 Mar 2023.